Cargando…
Antidiabetic therapies and Alzheimer disease
Given current lack of therapies for dementia, there is substantial interest in identifying potentially modifiable risk factors. Clarifying the potential of these factors to mitigate risk as well as determining the mechanisms that link these factors to dementia is expected to lead to new approaches f...
Autor principal: | Bendlin, Barbara B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780353/ https://www.ncbi.nlm.nih.gov/pubmed/31607783 |
Ejemplares similares
-
The iterative process of fluid biomarker development and validation in Alzheimer's disease
por: Bendlin, Barbara B., et al.
Publicado: (2022) -
Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
por: Michailidis, Michalis, et al.
Publicado: (2022) -
Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives
por: Femminella, Grazia Daniela, et al.
Publicado: (2017) -
New therapeutic strategy for Alzheimer's disease using antidiabetes agents
por: Yokono, Koichi
Publicado: (2013) -
Causal association evaluation of diabetes with Alzheimer's disease and genetic analysis of antidiabetic drugs against Alzheimer's disease
por: Meng, Lei, et al.
Publicado: (2022)